MktsMarkets

Karyopharm Therapeutics Inc.
NASDAQ: KPTIKey statistics
KPTI News
Stories mentioning KPTI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 35,066 | 34,079 | 44,044 | 37,929 | 30,015 | 30,542 | 38,783 | 42,786 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 33,797 | 27,667 | 30,544 | 32,788 | 34,618 | 33,302 | 36,134 | 38,371 |
| Sales General & Admin | 26,684 | 22,772 | 26,607 | 28,477 | 27,352 | 27,190 | 27,632 | 31,070 |
| Total Operating Expenses | 61,826 | 51,923 | 59,264 | 62,316 | 63,271 | 61,823 | 65,066 | 70,906 |
| Operating Income (Loss) | (26,760) | (17,844) | (15,220) | (24,387) | (33,256) | (31,281) | (26,283) | (28,120) |
| Interest Income | 511.00 | 607.00 | 553.00 | 613.00 | 1,000 | 1,482 | 1,832 | 1,930 |
| Interest Expense | 8,949 | |||||||
| Other Expense | 16,411 | (10,044) | (7,418) | (2,210) | 19,824 | 10,114 | 3,792 | 14,296 |
| Pretax Income | (22,391) | (102,265) | (33,093) | (37,212) | (23,426) | (30,889) | (32,044) | 23,859 |
| Tax Provision | 1.00 | (67.00) | 34.00 | 40.00 | 36.00 | (109.00) | 28.00 | 67.00 |
| Net Income (Loss) | (22,392) | (102,198) | (33,127) | (37,252) | (23,462) | (30,780) | (32,072) | 23,792 |
| Earnings Per Share (Basic) | (1.02) | (9,291) | (3.82) | (4.32) | (2.77) | (3,848) | (3.85) | 2.26 |
| Earnings Per Share (Diluted) | (1.24) | (9,291) | (3.82) | (4.32) | (2.77) | (3,848) | (3.85) | (2.97) |
| Weighted Average Shares Outstanding (Basic) | 22.00 | 11.00 | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Weighted Average Shares Outstanding (Diluted) | 25.00 | 11.00 | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 | 10.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KPTI
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) is a stock listed on the Nasdaq Stock Market under the ticker symbol KPTI. It last traded at $0.0600 (Nov 6, 2026, 9:30 AM ET), down 8.3% on the day. That gives Karyopharm Therapeutics a market capitalisation of $12.4M.
Over the past 52 weeks KPTI has traded between $0.0400 and $10.99.
Revenue for the quarter ended Mar 31, 2026 was $35.1M; a net loss of $22.4M. Revenue was up 16.8% from $30.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $35.1M | -$22.4M | -63.9% |
| Dec 31, 2025 | $34.1M | -$102.2M | -299.9% |
| Sep 30, 2025 | $44.0M | -$33.1M | -75.2% |
| Jun 30, 2025 | $37.9M | -$37.3M | -98.2% |
From Karyopharm Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…